Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | BRD4 | O60885 | 9/20 | 0.44 |
| ▸ | CREBBP | Q92793 | 9/20 | 0.44 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | CCR8 | P51685 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25499650 | 0.84 | ALDH1A1 (0.62) | ALDH1A1BRD4CREBBPEP300CCR8 | |
| SCHEMBL26351301 | 0.84 | ALDH1A1 (0.47) | ALDH1A1CCR8PKMLMNAMAPT | |
| SCHEMBL3919961 | 0.81 | ALDH1A1 (1.00) | ALDH1A1BRD4CREBBPEP300LMNA | |
| SCHEMBL30863319 | 0.81 | ALDH1A1 (1.00) | ALDH1A1BRD4CREBBPEP300LMNA | |
| SCHEMBL1843998 | 0.81 | ALDH1A1 (1.00) | ALDH1A1BRD4CREBBPEP300LMNA | |
| SCHEMBL3916768 | 0.81 | ALDH1A1 (1.00) | ALDH1A1BRD4CREBBPEP300LMNA | |
| SCHEMBL29990165 | 0.81 | ALDH1A1 (1.00) | ALDH1A1BRD4CREBBPEP300LMNA | |
| SCHEMBL19960824 | 0.80 | ALDH1A1 (0.61) | ALDH1A1BRD4CREBBPCCR8LMNA | |
| SCHEMBL19960823 | 0.80 | ALDH1A1 (0.61) | ALDH1A1BRD4CREBBPCCR8LMNA | |
| SCHEMBL19960511 | 0.80 | ALDH1A1 (0.61) | ALDH1A1BRD4CREBBPCCR8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018047983-A1 | INDANE DERIVATIVES USEFUL AS MODULATORS OF MGLUR7 | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-03-15 | — | — | WO | disclosed |